Accenture Presents: Data Preparation for a Successful Exit - Due Diligence the Importance of Standards

Tuesday, February 5 2013
8:30 am – 11:30 am

This event was posted by Accenture

Event Inquiries

ashli.j.davis@accenture.com

Location: MassBio Council 300 Technology Square 8th Floor Cambridge, MA 02139

Join us for an exclusive complimentary breakfast event featuring Accenture's clinical and regulatory thought-leaders.

Due diligence activities are mission critical for those looking to in-license or out-license compounds and biologics.  During this process, emerging companies can overlook the quality and integrity of their clinical and non-clinical study data.  By introducing data standards into the overall process, organizations can rest at ease knowing that data is organized in a standards-driven manner.

Topics to be Discussed

This seminar will discuss the due diligence process from both a clinical and regulatory perspective.

  • Process background
  • Standardized data management-related activities with a focus on an acquisition
  • Biostatistics-related activities with a focus on safety and efficacy
  • Importance of standards at the regulatory stage
  • Blinded Case Study

Featured Speakers

This session will feature the following panel of thought-leaders:

  • Nancy Smerkanich
    - Regulatory Affairs Consulting
  • Jeff Davidson
    - Biostatistics, Clinical Statistics
  • David Izard
    - Data Integration and Standardization

You Must Register to Attend:  http://www2.octagonresearch.com/l/5092/2013-01-03/q6lv7

Share MassBio

 

EvaluatePharma

 

MassBio